Arysta To Acquire Grupo Bioquimico Mexicano
The deal, which is pending regulatory approval, includes GBM and its subsidiaries, affiliated real estate and employee service companies, as well as GBM’s formulation and manufacturing facilities in Ramos Arizpe, Coahuila, Mexico. Chris Richards, president and CEO of Arysta LifeScience, said, “By combining the global strength of Arysta LifeScience with GBM’s outstanding product line and marketing expertise, growers in Mexico, Central, and South America and other targeted regions around the world will have access to new, innovative products and services that will help them manage their businesses more effectively. This acquisition is an important step in the development of the Arysta LifeScience global business in horticulture, which is one of our key focus markets.”